Do analysts recommend ADGM or INBS?

Adagio Medical presently has a consensus price target of $3.50, indicating a potential upside of 405.63%. Given Adagio Medical's stronger consensus rating and higher possible upside, research analysts clearly believe Adagio Medical is more favorable than Intelligent Bio Solutions. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adagio Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Intelligent Bio Solutions 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media refer more to ADGM or INBS?

In the previous week, Adagio Medical had 1 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 4 mentions for Adagio Medical and 3 mentions for Intelligent Bio Solutions. Intelligent Bio Solutions' average media sentiment score of 1.36 beat Adagio Medical's score of -0.28 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adagio Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Intelligent Bio Solutions 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer INBS or TMDIF?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intelligent Bio Solutions 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Titan Medical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts prefer ICU or INBS?

SeaStar Medical presently has a consensus price target of $8.00, suggesting a potential upside of 151.57%. Given SeaStar Medical's stronger consensus rating and higher possible upside, analysts plainly believe SeaStar Medical is more favorable than Intelligent Bio Solutions. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SeaStar Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Intelligent Bio Solutions 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media refer more to ICU or INBS?

In the previous week, SeaStar Medical had 4 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 7 mentions for SeaStar Medical and 3 mentions for Intelligent Bio Solutions. Intelligent Bio Solutions' average media sentiment score of 1.36 beat SeaStar Medical's score of 0.71 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SeaStar Medical 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Intelligent Bio Solutions 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer IRIX or INBS?

IRIDEX currently has a consensus price target of $3.00, indicating a potential upside of 250.47%. Given IRIDEX's stronger consensus rating and higher possible upside, equities research analysts plainly believe IRIDEX is more favorable than Intelligent Bio Solutions. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IRIDEX 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Intelligent Bio Solutions 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Intelligent Bio Solutions (INBS) Competitors

$2.77 -0.23 (-7.67%)

Closing price 04:00 PM Eastern

Extended Trading

$2.88 +0.11 (+3.94%)

As of 07:04 PM Eastern

Compare

INBS vs. ADGM, TMDIF, ICU, IRIX, and NMTC

Should you buy Intelligent Bio Solutions stock or one of its competitors? Intelligent Bio Solutions's main competitors and comparable companies include Adagio Medical (ADGM), Titan Medical (TMDIF), SeaStar Medical (ICU), IRIDEX (IRIX), and NeuroOne Medical Technologies (NMTC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Intelligent Bio Solutions compare to Adagio Medical?

Adagio Medical (NASDAQ:ADGM) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership.

Intelligent Bio Solutions has higher revenue and earnings than Adagio Medical. Adagio Medical is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adagio Medical	$600K	25.62	-$25.08M	-$1.53	N/A
Intelligent Bio Solutions	$3.05M	2.17	-$10.57M	-$12.22	N/A

Adagio Medical has a beta of -0.15, indicating that its stock price is 115% less volatile than the broader market. Comparatively, Intelligent Bio Solutions has a beta of 4.21, indicating that its stock price is 321% more volatile than the broader market.

Adagio Medical presently has a consensus price target of $3.50, indicating a potential upside of 405.63%. Given Adagio Medical's stronger consensus rating and higher possible upside, research analysts clearly believe Adagio Medical is more favorable than Intelligent Bio Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Intelligent Bio Solutions	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Adagio Medical has a net margin of 0.00% compared to Intelligent Bio Solutions' net margin of -296.73%. Intelligent Bio Solutions' return on equity of -176.09% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adagio Medical	N/A	-661.85%	-73.35%
Intelligent Bio Solutions	-296.73%	-176.09%	-89.71%

48.1% of Adagio Medical shares are held by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are held by institutional investors. 7.8% of Adagio Medical shares are held by insiders. Comparatively, 1.3% of Intelligent Bio Solutions shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Adagio Medical had 1 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 4 mentions for Adagio Medical and 3 mentions for Intelligent Bio Solutions. Intelligent Bio Solutions' average media sentiment score of 1.36 beat Adagio Medical's score of -0.28 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Adagio Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Intelligent Bio Solutions	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Adagio Medical beats Intelligent Bio Solutions on 10 of the 16 factors compared between the two stocks.

How does Intelligent Bio Solutions compare to Titan Medical?

Intelligent Bio Solutions (NASDAQ:INBS) and Titan Medical (NASDAQ:TMDIF) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, profitability, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and risk.

In the previous week, Intelligent Bio Solutions had 3 more articles in the media than Titan Medical. MarketBeat recorded 3 mentions for Intelligent Bio Solutions and 0 mentions for Titan Medical. Intelligent Bio Solutions' average media sentiment score of 1.36 beat Titan Medical's score of 0.00 indicating that Intelligent Bio Solutions is being referred to more favorably in the media.

Company	Overall Sentiment
Intelligent Bio Solutions	Positive
Titan Medical	Neutral

Intelligent Bio Solutions has a beta of 4.21, meaning that its stock price is 321% more volatile than the broader market. Comparatively, Titan Medical has a beta of 1.26, meaning that its stock price is 26% more volatile than the broader market.

Titan Medical has higher revenue and earnings than Intelligent Bio Solutions. Intelligent Bio Solutions is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intelligent Bio Solutions	$3.05M	2.17	-$10.57M	-$12.22	N/A
Titan Medical	$17.63M	0.95	$6.95M	$0.05	2.93

Titan Medical has a net margin of 0.00% compared to Intelligent Bio Solutions' net margin of -296.73%. Titan Medical's return on equity of -82.31% beat Intelligent Bio Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intelligent Bio Solutions	-296.73%	-176.09%	-89.71%
Titan Medical	N/A	-82.31%	-51.47%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intelligent Bio Solutions	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Titan Medical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

33.0% of Intelligent Bio Solutions shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 1.3% of Intelligent Bio Solutions shares are owned by insiders. Comparatively, 0.0% of Titan Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Intelligent Bio Solutions and Titan Medical tied by winning 7 of the 14 factors compared between the two stocks.

How does Intelligent Bio Solutions compare to SeaStar Medical?

SeaStar Medical (NASDAQ:ICU) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability, media sentiment and analyst recommendations.

In the previous week, SeaStar Medical had 4 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 7 mentions for SeaStar Medical and 3 mentions for Intelligent Bio Solutions. Intelligent Bio Solutions' average media sentiment score of 1.36 beat SeaStar Medical's score of 0.71 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SeaStar Medical	0 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Intelligent Bio Solutions	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

SeaStar Medical has a beta of -1.05, indicating that its share price is 205% less volatile than the broader market. Comparatively, Intelligent Bio Solutions has a beta of 4.21, indicating that its share price is 321% more volatile than the broader market.

1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are owned by institutional investors. 0.7% of SeaStar Medical shares are owned by company insiders. Comparatively, 1.3% of Intelligent Bio Solutions shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Intelligent Bio Solutions has higher revenue and earnings than SeaStar Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SeaStar Medical	$1.23M	11.40	-$12.15M	-$4.80	N/A
Intelligent Bio Solutions	$3.05M	2.17	-$10.57M	-$12.22	N/A

SeaStar Medical presently has a consensus price target of $8.00, suggesting a potential upside of 151.57%. Given SeaStar Medical's stronger consensus rating and higher possible upside, analysts plainly believe SeaStar Medical is more favorable than Intelligent Bio Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SeaStar Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Intelligent Bio Solutions	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Intelligent Bio Solutions has a net margin of -296.73% compared to SeaStar Medical's net margin of -795.51%. SeaStar Medical's return on equity of -162.75% beat Intelligent Bio Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SeaStar Medical	-795.51%	-162.75%	-109.89%
Intelligent Bio Solutions	-296.73%	-176.09%	-89.71%

Summary

Intelligent Bio Solutions beats SeaStar Medical on 9 of the 16 factors compared between the two stocks.

How does Intelligent Bio Solutions compare to IRIDEX?

IRIDEX (NASDAQ:IRIX) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, valuation, institutional ownership and dividends.

IRIDEX has a net margin of -6.23% compared to Intelligent Bio Solutions' net margin of -296.73%. IRIDEX's return on equity of 0.00% beat Intelligent Bio Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.23%	N/A	-11.16%
Intelligent Bio Solutions	-296.73%	-176.09%	-89.71%

IRIDEX has higher revenue and earnings than Intelligent Bio Solutions. IRIDEX is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.28	-$4.44M	-$0.19	N/A
Intelligent Bio Solutions	$3.05M	2.17	-$10.57M	-$12.22	N/A

20.1% of IRIDEX shares are held by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are held by institutional investors. 8.6% of IRIDEX shares are held by company insiders. Comparatively, 1.3% of Intelligent Bio Solutions shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Intelligent Bio Solutions had 2 more articles in the media than IRIDEX. MarketBeat recorded 3 mentions for Intelligent Bio Solutions and 1 mentions for IRIDEX. IRIDEX's average media sentiment score of 1.89 beat Intelligent Bio Solutions' score of 1.36 indicating that IRIDEX is being referred to more favorably in the media.

Company	Overall Sentiment
IRIDEX	Very Positive
Intelligent Bio Solutions	Positive

IRIDEX currently has a consensus price target of $3.00, indicating a potential upside of 250.47%. Given IRIDEX's stronger consensus rating and higher possible upside, equities research analysts plainly believe IRIDEX is more favorable than Intelligent Bio Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Intelligent Bio Solutions	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

IRIDEX has a beta of 0.66, indicating that its stock price is 34% less volatile than the broader market. Comparatively, Intelligent Bio Solutions has a beta of 4.21, indicating that its stock price is 321% more volatile than the broader market.

Summary

IRIDEX beats Intelligent Bio Solutions on 11 of the 16 factors compared between the two stocks.

How does Intelligent Bio Solutions compare to NeuroOne Medical Technologies?

NeuroOne Medical Technologies (NASDAQ:NMTC) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, earnings, analyst recommendations, risk and profitability.

NeuroOne Medical Technologies has a beta of 0.61, suggesting that its share price is 39% less volatile than the broader market. Comparatively, Intelligent Bio Solutions has a beta of 4.21, suggesting that its share price is 321% more volatile than the broader market.

NeuroOne Medical Technologies has higher revenue and earnings than Intelligent Bio Solutions. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroOne Medical Technologies	$12.10M	1.39	-$3.61M	-$0.85	N/A
Intelligent Bio Solutions	$3.05M	2.17	-$10.57M	-$12.22	N/A

NeuroOne Medical Technologies has a net margin of -71.50% compared to Intelligent Bio Solutions' net margin of -296.73%. NeuroOne Medical Technologies' return on equity of -115.61% beat Intelligent Bio Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeuroOne Medical Technologies	-71.50%	-115.61%	-79.63%
Intelligent Bio Solutions	-296.73%	-176.09%	-89.71%

NeuroOne Medical Technologies presently has a consensus target price of $7.33, suggesting a potential upside of 278.01%. Given NeuroOne Medical Technologies' stronger consensus rating and higher probable upside, equities analysts clearly believe NeuroOne Medical Technologies is more favorable than Intelligent Bio Solutions.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeuroOne Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Intelligent Bio Solutions	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, NeuroOne Medical Technologies had 2 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 5 mentions for NeuroOne Medical Technologies and 3 mentions for Intelligent Bio Solutions. Intelligent Bio Solutions' average media sentiment score of 1.36 beat NeuroOne Medical Technologies' score of 0.77 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NeuroOne Medical Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Intelligent Bio Solutions	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

16.1% of NeuroOne Medical Technologies shares are held by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are held by institutional investors. 11.8% of NeuroOne Medical Technologies shares are held by insiders. Comparatively, 1.3% of Intelligent Bio Solutions shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

NeuroOne Medical Technologies beats Intelligent Bio Solutions on 11 of the 16 factors compared between the two stocks.

Get Intelligent Bio Solutions News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INBS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

INBS vs. The Competition

Export

Metric	Intelligent Bio Solutions	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$7.18M	$5.95B	$7.06B	$13.10B
Dividend Yield	N/A	1.76%	2.57%	10.45%
P/E Ratio	-0.23	26.22	269.06	25.28
Price / Sales	2.17	63.09	602.43	91.76
Price / Cash	N/A	33.92	70.48	50.90
Price / Book	0.68	6.10	12.91	6.24
Net Income	-$10.57M	$148.67M	$3.45B	$347.60M
7 Day Performance	39.90%	1.84%	1.12%	1.07%
1 Month Performance	23.11%	4.56%	1.79%	1.03%
1 Year Performance	-81.28%	8.67%	67.69%	20.77%

Intelligent Bio Solutions Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
INBS Intelligent Bio Solutions	1.3266 of 5 stars	$2.77 -7.7%	N/A	-80.1%	$7.18M	$3.05M	N/A	10	Positive News Short Interest Decrease Gap Down
ADGM Adagio Medical	2.2985 of 5 stars	$0.72 -3.4%	$3.50 +386.7%	-45.7%	$16.53M	$600K	N/A	87	Earnings Report
TMDIF Titan Medical	N/A	$0.13 -3.3%	N/A	-61.9%	$15.23M	$17.63M	N/A	50	Gap Down
ICU SeaStar Medical	2.8258 of 5 stars	$3.69 flat	$8.00 +116.8%	-56.6%	$14.75M	$1.23M	N/A	2	News Coverage Earnings Report
IRIX IRIDEX	2.6177 of 5 stars	$0.89 +5.7%	$3.00 +237.2%	-30.2%	$14.65M	$52.67M	N/A	120	Positive News Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:INBS) was last updated on 8/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Intelligent Bio Solutions (INBS) Competitors

INBS vs. ADGM, TMDIF, ICU, IRIX, and NMTC

How does Intelligent Bio Solutions compare to Adagio Medical?

Summary

How does Intelligent Bio Solutions compare to Titan Medical?

Summary

How does Intelligent Bio Solutions compare to SeaStar Medical?

Summary

How does Intelligent Bio Solutions compare to IRIDEX?

Summary

How does Intelligent Bio Solutions compare to NeuroOne Medical Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INBS vs. The Competition

Intelligent Bio Solutions Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Intelligent Bio Solutions (INBS) Competitors

INBS vs. ADGM, TMDIF, ICU, IRIX, and NMTC

How does Intelligent Bio Solutions compare to Adagio Medical?

Which has preferable earnings & valuation, ADGM or INBS?

Which has more volatility & risk, ADGM or INBS?

Do analysts recommend ADGM or INBS?

Is ADGM or INBS more profitable?

Do institutionals and insiders believe in ADGM or INBS?

Does the media refer more to ADGM or INBS?

Summary

How does Intelligent Bio Solutions compare to Titan Medical?

Does the media favor INBS or TMDIF?

Which has more volatility and risk, INBS or TMDIF?

Which has preferable valuation and earnings, INBS or TMDIF?

Is INBS or TMDIF more profitable?

Do analysts prefer INBS or TMDIF?

Do institutionals & insiders have more ownership in INBS or TMDIF?

Summary

How does Intelligent Bio Solutions compare to SeaStar Medical?

Does the media refer more to ICU or INBS?

Which has more risk & volatility, ICU or INBS?

Do institutionals and insiders have more ownership in ICU or INBS?

Which has higher valuation & earnings, ICU or INBS?

Do analysts prefer ICU or INBS?

Is ICU or INBS more profitable?

Summary

How does Intelligent Bio Solutions compare to IRIDEX?

Is IRIX or INBS more profitable?

Which has stronger valuation & earnings, IRIX or INBS?

Do institutionals & insiders believe in IRIX or INBS?

Does the media prefer IRIX or INBS?

Do analysts prefer IRIX or INBS?

Which has more risk and volatility, IRIX or INBS?

Summary

How does Intelligent Bio Solutions compare to NeuroOne Medical Technologies?

Which has more volatility & risk, NMTC or INBS?

Which has preferable valuation & earnings, NMTC or INBS?

Is NMTC or INBS more profitable?

Do analysts recommend NMTC or INBS?

Does the media refer more to NMTC or INBS?

Do insiders & institutionals have more ownership in NMTC or INBS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INBS vs. The Competition

Intelligent Bio Solutions Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools